Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TALPHERA, INC.TLPH · Entity 7102 | Director · CHIEF EXECUTIVE OFFICER | April 02, 2026 | April 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TALPHERA, INC.
Report date April 02, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 790,767 |
Reported balance
After 2026-04-02 transaction · row 1
1 source rowRow 1 · 2026-04-02 · Tax withholding · Disposed 9,938 · Balance 790,767 F1: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2019 Filed Feb 13, 2019 22:40 UTC | TALPHERA, INC. ACRX · Entity 7102 | GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $2.51 | $0.00 |
DisclosureSEC source: 0001209191-19-009806 · doc4.xml · derivative · entry 2 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2029-02-11 F3 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:40 UTC | TALPHERA, INC. ACRX · Entity 7102 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009806 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,650 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 11, 2020, February 11, 2021 and February 11, 2022. Read SEC document |
| December 14, 2018 Filed Dec 17, 2018 17:05 UTC | TALPHERA, INC. ACRX · Entity 7102 | PurchaseCommon Stock | 3,610 | $2.78 | $10,023.53 |
DisclosureSEC source: 0001209191-18-062871 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,650 Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 00:31 UTC | TALPHERA, INC. ACRX · Entity 7102 | PurchaseCommon Stock | 10,000 | $2.99 | $29,890.00 |
DisclosureSEC source: 0001209191-18-062333 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,040 F1 · price: This is a weighted average purchase price. Shares were purchased in the range of $2.98 and $2.99. Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 21:50 UTC | TALPHERA, INC. ACRX · Entity 7102 | GrantStock Option (Right to Buy) · Derivative | 96,250 | $0.00 Strike: $2.23 | $0.00 |
DisclosureSEC source: 0001209191-18-057212 · doc4.xml · derivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,250 Underlying: Common Stock · 96,250 shares Expires 2028-11-02 F1 · balance_after: On April 7, 2018, the reporting person was granted an option to purchase 192,500 shares of common stock. The option vests in two equal annual installments based on Company's achievement of commercial approval by the U.S. Food and Drug Administration ("FDA") of its new drug application for "DSUVIA" on or before February 15, 2019; and the remaining 50% of the award shall vest on the one-year anniversary of the date of such FDA approval, in all cases subject to continuous service to the Company. The performance criteria for commercial approval by the FDA for DSUVIA was met on November 2, 2018, resulting in vesting of the option as to 96,250 shares. Read SEC document |
| August 31, 2018 Filed Sep 5, 2018 10:06 UTC | TALPHERA, INC. ACRX · Entity 7102 | GrantCommon Stock | 6,040 | $1.49 | $8,999.60 |
DisclosureSEC source: 0000899243-18-023788 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,040 F1 · kind: These shares were acquired under the Company's Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d)and Rule 16b-3(c). Read SEC document |
| August 07, 2018 Filed Aug 7, 2018 20:08 UTC | TALPHERA, INC. ACRX · Entity 7102 | PurchaseCommon Stock | 10,000 | $2.90 | $28,950.00 |
DisclosureSEC source: 0001209191-18-045663 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 F1 · balance_after: Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| January 22, 2018 Filed Jan 27, 2018 00:27 UTC | TALPHERA, INC. ACRX · Entity 7102 | GrantStock Option (Right to Buy) · Derivative | 350,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001437749-18-001227 · rdgdoc.xml · derivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2028-01-21 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (August 16, 2018) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. Read SEC document |
| August 24, 2017 Filed Aug 24, 2017 22:14 UTC | TALPHERA, INC. ACRX · Entity 7102 | PurchaseCommon Stock | 15,000 | $3.00 | $45,000.00 |
DisclosureSEC source: 0001437749-17-015261 · rdgdoc.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 21:35 UTC | TALPHERA, INC. ACRX · Entity 7102 | GrantStock Option (Right to Buy) · Derivative | 800,000 | $0.00 Strike: $3.30 | $0.00 |
DisclosureSEC source: 0001437749-17-003950 · rdgdoc.xml · derivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2027-03-05 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (March 6, 2018) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. F3 · derivative.exercise_date: The shares have double-trigger acceleration on a change of control Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.